Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium + colecalciferol is a fixed-dose combination nutritional supplement and pharmaceutical product used to maintain bone health and treat mineral deficiencies. Calcium is an essential mineral required for bone mineralization, neuromuscular function, and enzymatic processes. Colecalciferol (Vitamin D3) is a fat-soluble vitamin that acts as a precursor to calcitriol, the active form of Vitamin D, which enhances the intestinal absorption of calcium and regulates calcium-phosphorus homeostasis. This combination is widely utilized as an adjunct to specific osteoporosis treatments and for the prevention and treatment of rickets and osteomalacia. It is available in various oral formulations, including tablets, chewable tablets, and syrups, and is marketed globally by numerous pharmaceutical companies, including Chemross Lifesciences in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium + colecalciferol.